Our team have the expertise and equipment to design and run the optimal screening approach for your target – from High Throughput Screening (HTS), utilising libraries of hundreds-of-thousands of compounds, through to fragment-, focused- and diversity-based approaches. We help you analyse and interpret the data, recommending next steps, deploying hypothesis-based medicinal chemistry, and making a genuine scientific contribution to your project team. If required, we offer access to an in house diversity-based library of 125K IP-free molecules available via Compound Cloud, and an in-house fragment subset of the above.
Key expertise includes:
A wide range of capabilities and techniques, including: